Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure-Reference-Cited by-同舟云学术

Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure

Published:2017 Issue:1 Volume:79 Page:29-34
ISSN:0916-7250
Container-title:Journal of Veterinary Medical Science
language:en
Short-container-title:The Journal of Veterinary Medical Science

Author:

MIZUNO Masashi¹,YAMANO Shigeki¹,CHIMURA Shuichi²,HIRAKAWA Atsushi³,TAKUSAGAWA Yoshimi¹,SAWADA Tamotsu¹,MAETANI Shigeki⁴,TAKAHASHI Arane¹,MIZUNO Takeshi¹,HARADA Kayoko¹,SHINODA Asako¹,UCHIDA Shuhei¹,TAKEUCHI Junichiro¹,MIZUKOSHI Takahiro¹,ENDO Masaaki¹,UECHI Masami¹

Affiliation:

1. Japan Animal Specialty Medical Institute Inc., JASMINE Veterinary Cardiovascular Medical Center, 2-7-3 Nakagawa, Tsuzuki, Yokohama, Kanagawa 224-0001, Japan

2. Chimura Animal Hospital, 20-13, Minami Karooke, Nakamatomachi, Iwakura, Aichi 482-0042, Japan

3. Pet Clinic Halleluya, 1-30-63, Heiwa, Minami-ku, Fukuoka, Fukuoka 815-0071, Japan

4. Maetani Animal Hospital, 3 Jou, 1-1-7, Taihei, Kita-ku, Sapporo, Hokkaido 002-8003 Japan

Publisher

Japanese Society of Veterinary Science

Subject

General Veterinary

Link

https://www.jstage.jst.go.jp/article/jvms/79/1/79_16-0069/_pdf

Reference24 articles.

1. 1. Atkins, C., Bonagura, J., Ettinger, S., Fox, P., Gordon, S., Häggström, J., Hamlin, R., Keene, B., Luis-Fuentes, V. and Stepien, R. 2009. Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J. Vet. Intern. Med. 23: 1142–1150.

2. 2. BENCH (BENazepril in Canine Heart disease) Study Group. 1999. The effect of benazepril on survival times and clinical signs of dogs with congestive heart failure: Results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial. J. Vet. Cardiol. 1: 7–18.

3. 3. Bernay, F., Bland, J. M., Häggström, J., Baduel, L., Combes, B., Lopez, A. and Kaltsatos, V. 2010. Efficacy of spironolactone on survival in dogs with naturally occurring mitral regurgitation caused by myxomatous mitral valve disease. J. Vet. Intern. Med. 24: 331–341.

4. 4. Boon, J. A. 2011. Evaluation of size, function, and hemodynamics. pp. 153–266. In: Veterinary Echocardiography, 2nd ed., Wiley-Blackwell, Hoboken.

5. 5. Borgarelli, M., Savarino, P., Crosara, S., Santilli, R. A., Chiavegato, D., Poggi, M., Bellino, C., La Rosa, G., Zanatta, R., Häggström, J. and Tarducci, A. 2008. Survival characteristics and prognostic variables of dogs with mitral regurgitation attributable to myxomatous valve disease. J. Vet. Intern. Med. 22: 120–128.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential prognostic indicators in dogs with advanced heart failure secondary to myxomatous mitral valve disease;Veterinary Record;2024-07-03

2. Pimobendan controlled release guar gum printlets: Tailoring drug doses for personalised veterinary medicines;International Journal of Pharmaceutics;2024-04

3. Pharmacokinetics of pimobendan after oral administration to dogs with myxomatous mitral valve disease;Journal of Veterinary Internal Medicine;2023-09-30

4. Selected hematological, biochemical, and echocardiographic variables as predictors of survival in canine patients with myxomatous mitral valve disease and congestive heart failure;Journal of Veterinary Cardiology;2023-04

5. Use of the Functional Evaluation of Cardiac Health questionnaire to assess health-related quality of life before and after mitral valve repair in dogs with myxomatous mitral valve disease;Journal of the American Veterinary Medical Association;2022-05-20